stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Moonlake ImmunotherapeuticsMLTX
$11.472.63%-0.31

Moonlake Immunotherapeutics (MLTX)

Date: 2026-11-02 16:00O: 11.80H: 12.00L: 11.17C: 11.47Vol: 972.0k
Schlusskurs vom Vortag:
$11.78
Offen:
$11.80
24-Stunden-Volumen:
972,019
Relatives Volumen:
0.48
Marktkapitalisierung:
$976.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
-$230.32M
KGV:
-
EPS:
-$3.53
Netto-Cashflow:
-$196.04M
1W Leistung:
-3.86%
1M Leistung:
+0.53%
6M Leistung:
-31.44%
1Y Leistung:
+12.45%
1-Tages-Spanne:
$0.00$0.00
1-Wochen-Bereich:
$11.17$12.95
52-Wochen-Spanne:
$9.46$23.29

Moonlake Immunotherapeutics Aktie (MLTX) Unternehmensprofil

Firmenname
Moonlake Immunotherapeutics
Telefon
41 41 510 8022
Adresse
DORFSTRASSE 29, ZUG, Switzerland
Mitarbeiter
130
X
-
Nächster Verdiensttermin
2026-11-04
Neueste SEC-Einreichungen
SEC
MLTX-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Moonlake Immunotherapeutics Aktie (MLTX) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-03-23HochstufungWolfe ResearchUnderperform → Outperform
2026-03-19HochstufungRothschild & Co RedburnNeutral → Buy
2026-01-15HerabstufungGoldmanNeutral → Sell
2026-01-09HochstufungBTIG ResearchNeutral → Buy

Finanzdaten der Moonlake Immunotherapeutics-Aktie (MLTX)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022
Enddatum des Zeitraums2025-12-312024-12-312023-12-312022-12-31
Revenue USD (M)--0.000.00
Research and development USD (M)202.86112.7731.8042.05
Operating expenses USD (M)244.83143.0954.1265.06
Operating income USD (M)-244.83-143.09-54.12-65.06
Income before tax USD (M)-229.71-120.96-43.98-64.47
Income tax expense USD (M)0.610.280.090.04
Net income USD (M)-230.32-121.24-44.08-64.51
Basic EPS USD/shares-3.53-1.89-0.73-1.70
Diluted EPS USD/shares-3.53-1.89-0.73-1.70
Basic weighted shares shares (M)64.4662.8749.1229.36
Diluted weighted shares shares (M)64.4662.8749.1229.36

Moonlake Immunotherapeutics-Aktie (MLTX) Insiderhandel

  • Reich KristianJul 27 '26
    Chief Scientific Officer
    Transaktion
    Sale
    Kosten
    $20.00
    #Aktien
    1,100
    Wert ($)
    22,000
    #Aktien Gesamt
    2,711,198
  • Reich KristianJul 22 '26
    Chief Scientific Officer
    Transaktion
    Sale
    Kosten
    $20.00
    #Aktien
    2,448
    Wert ($)
    48,960
    #Aktien Gesamt
    2,712,298
  • Reich KristianJul 21 '26
    Chief Scientific Officer
    Transaktion
    Sale
    Kosten
    $20.02
    #Aktien
    50,000
    Wert ($)
    1,001,000
    #Aktien Gesamt
    2,714,746
  • Reich KristianJul 20 '26
    Chief Scientific Officer
    Transaktion
    Sale
    Kosten
    $20.09
    #Aktien
    43,700
    Wert ($)
    877,933
    #Aktien Gesamt
    2,764,746
  • Reich KristianJul 15 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $19.44
    #Aktien
    150,000
    Wert ($)
    2,916,000
    #Aktien Gesamt
    0
  • Reich KristianJul 15 '26
    Chief Scientific Officer
    Transaktion
    Sale
    Kosten
    $20.01
    #Aktien
    16,105
    Wert ($)
    322,261
    #Aktien Gesamt
    2,808,446
  • Chief Executive Officer
    Transaktion
    Sale
    Kosten
    $20.02
    #Aktien
    68,289
    Wert ($)
    1,367,146
    #Aktien Gesamt
    2,774,893
  • Chief Executive Officer
    Transaktion
    Sale
    Kosten
    $20.01
    #Aktien
    33,936
    Wert ($)
    679,059
    #Aktien Gesamt
    2,843,182
  • Chief Executive Officer
    Transaktion
    Sale
    Kosten
    $20.03
    #Aktien
    47,775
    Wert ($)
    956,933
    #Aktien Gesamt
    2,877,118
  • Officer
    Transaktion
    Proposed Sale
    Kosten
    $20.03
    #Aktien
    150,000
    Wert ($)
    3,004,500
    #Aktien Gesamt
    0
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
Reich KristianChief Scientific OfficerJul 27 '26Sale$20.001,10022,0002,711,198
Reich KristianChief Scientific OfficerJul 22 '26Sale$20.002,44848,9602,712,298
Reich KristianChief Scientific OfficerJul 21 '26Sale$20.0250,0001,001,0002,714,746
Reich KristianChief Scientific OfficerJul 20 '26Sale$20.0943,700877,9332,764,746
Reich KristianOfficerJul 15 '26Proposed Sale$19.44150,0002,916,0000
Reich KristianChief Scientific OfficerJul 15 '26Sale$20.0116,105322,2612,808,446
Santos da Silva JorgeChief Executive OfficerJul 10 '26Sale$20.0268,2891,367,1462,774,893
Santos da Silva JorgeChief Executive OfficerJul 09 '26Sale$20.0133,936679,0592,843,182
Santos da Silva JorgeChief Executive OfficerJul 01 '26Sale$20.0347,775956,9332,877,118
Santos da Silva JorgeOfficerJun 30 '26Proposed Sale$20.03150,0003,004,5000

Moonlake Immunotherapeutics Aktie (MLTX) Neueste Nachrichten

Sep 21, 2026
Sep 21, 2026
Sep 12, 2026
Sep 12, 2026
Sep 11, 2026
Sep 11, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 07, 2026
Sep 07, 2026
Sep 01, 2026
Sep 01, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 18, 2026
Aug 18, 2026
Aug 16, 2026
Aug 16, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026

Ähnlich wie MLTX